Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation: Answers to Challenging “Real-World” Questions

Dabigatran etexilate is a novel, oral, reversible, direct thrombin inhibitor that constitutes a major breakthrough for stroke prevention in patients with nonvalvular atrial fibrillation (AF). Dabigatran was the first new oral anticoagulant approved in Europe and became available in Portugal, for str...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Jorge, Ferreira, Daniel, Viana-Baptista, Miguel, Bettencourt, Paulo, Cernadas, Rui, Crespo, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356980/
https://www.ncbi.nlm.nih.gov/pubmed/22645678
http://dx.doi.org/10.1155/2012/867121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356980/
https://www.ncbi.nlm.nih.gov/pubmed/22645678
http://dx.doi.org/10.1155/2012/867121

Ejemplares similares